Tu

TUBERCULOSIS TREATMENT INDICATOR (HIV)
TUMOUR GRADE (FOR BREAST SCREENING)
TUMOUR GRADE (UROLOGY)
TUMOUR HEIGHT ABOVE ANAL VERGE
TUMOUR INFILTRATING LYMPHOCYTE TYPE
TUMOUR INVASION INDICATION CODE (DIRECT ADRENAL)
TUMOUR INVASION INDICATOR (CORPUS CAVERNOSUM)
TUMOUR INVASION INDICATOR (CORPUS SPONGIOSUM)
TUMOUR INVASION INDICATOR (DIAPHRAGM)
TUMOUR INVASION INDICATOR (GEROTAS FASCIA)
TUMOUR INVASION INDICATOR (GREAT VESSELS)
TUMOUR INVASION INDICATOR (HEART)
TUMOUR INVASION INDICATOR (MEDIASTINUM)
TUMOUR INVASION INDICATOR (PERICARDIUM)
TUMOUR INVASION INDICATOR (PERINEPHRIC FAT)
TUMOUR INVASION INDICATOR (PERIRENAL FAT)
TUMOUR INVASION INDICATOR (RENAL SINUS)
TUMOUR INVASION INDICATOR (RETE TESTIS)
TUMOUR INVASION INDICATOR (URETHRA OR PROSTATE)
TUMOUR LATERALITY
TUMOUR LATERALITY (PATHOLOGICAL)
TUMOUR LOCATION (SURGICAL)
TUMOUR NECROSIS INDICATION CODE
TUMOUR NECROSIS PERCENTAGE
TUMOUR REGRESSION INDICATION CODE (SKIN)
TUMOUR RUPTURE INDICATOR (PATHOLOGICAL)
TUMOUR VOLUME AT DIAGNOSIS CODE
TURP TUMOUR PERCENTAGE
TWO WEEK WAIT CANCER OR SYMPTOMATIC BREAST REFERRAL TYPE
TWO YEAR NEONATAL OUTCOMES ASSESSMENT DATE
TWO YEAR NEONATAL OUTCOMES ASSESSMENT NOT CARRIED OUT REASON
TWO YEAR NEONATAL OUTCOMES ASSESSMENT YEAR AND MONTH
ISO 9001 CERTIFICATION EUROPE